Key points are not available for this paper at this time.
Intermediate MoS2with rich active sites and desired stability was controllably synthesized and exhibits optimized catalytic activity of anthracene hydrogenation.
Li et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: